Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anebulo Pharmaceuticals, Inc.

1.13
+0.07707.33%
Post-market: 1.130.00000.00%16:00 EDT
Volume:5.66K
Turnover:6.13K
Market Cap:46.30M
PE:-4.40
High:1.13
Open:1.03
Low:1.03
Close:1.05
Loading ...

Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Waters (WAT) and Anebulo Pharmaceuticals (ANEB)

TIPRANKS
·
22 May

Anebulo Pharmaceuticals Is Maintained at Buy by Maxim Group

Dow Jones
·
16 May

Anebulo Pharmaceuticals Q3 EPS $(0.04) Beats $(0.05) Estimate

Benzinga
·
14 May

Anebulo Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

BRIEF-Anebulo Pharmaceuticals, Inc. Q3 Basic EPS USD -0.04

Reuters
·
14 May

Anebulo Pharmaceuticals Reports Q3 Fiscal 2025 Results: Net Loss Steady at $1.7 Million, EPS Improves to $(0.04)

Reuters
·
14 May

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates

THOMSON REUTERS
·
14 May

Press Release: Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates

Dow Jones
·
14 May

Anebulo Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
09 May

BRIEF-Anebulo Pharmaceuticals Inc Files For Resale Of Up To 15.15 Million Shares By The Selling Stockholders

Reuters
·
04 Mar

Anebulo Pharmaceuticals Inc Files for Resale of up to 15.15 Mln Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
04 Mar

Anebulo Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
15 Feb

Anebulo Pharmaceuticals reports Q4 EPS (9c) vs. (11c) last year

TIPRANKS
·
15 Feb

Anebulo Pharmaceuticals Q2 2025 GAAP EPS $(0.09) Misses $(0.08) Estimate

Benzinga
·
15 Feb

Anebulo Pharmaceuticals, Inc. Q2 Operating Expenses USD 2.6 Million

THOMSON REUTERS
·
15 Feb

Press Release: Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates

Dow Jones
·
15 Feb

Anebulo Pharmaceuticals Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
07 Feb

Anebulo Pharmaceuticals Leads This Trio Of US Penny Stocks

Simply Wall St.
·
05 Feb

Anebulo Pharmaceuticals collaborates with FDA to advance selonabant

TIPRANKS
·
23 Dec 2024

Anebulo Pharmaceuticals: Entered Stock Purchase Agreement for Issuance & Sale of 15.2 Mln Shares of Common Stock for $15 Mln

THOMSON REUTERS
·
23 Dec 2024